SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioReliance Corporation Announces Agreement with Barr Pharmaceuticals, Inc. to Supply Bulk Virus for the Manufacture of Adenovirus Vaccine for the U.S. Department of Defense